(Q42230452)

19 October 2017

title

Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists (English)

1 reference

19 October 2017

0 references

mesenchymal stem cell

1 reference

Xi Chen

1

1 reference

19 October 2017

Zheng-Yun Zhang

series ordinal

2

1 reference

19 October 2017

Hao Zhou

series ordinal

3

1 reference

19 October 2017

Guang-Wen Zhou

series ordinal

4

1 reference

19 October 2017

publication date

19 March 2014

1 reference

Development, Growth and Differentiation

19 October 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 October 2017

volume

56

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

233-244

1 reference

Toll-like receptors: critical proteins linking innate and acquired immunity

19 October 2017

cites work

1 reference

Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells

21 January 2018

1 reference

Role of toll-like receptors on human adipose-derived stromal cells.

21 January 2018

1 reference

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

21 January 2018

1 reference

Toll-like receptors: linking innate and adaptive immunity

21 January 2018

1 reference

Toll-like receptors and their ligands control mesenchymal stem cell functions

21 January 2018

1 reference

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.

21 January 2018

1 reference

Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.

21 January 2018

1 reference

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

21 January 2018

1 reference

MSCs: Biological characteristics, clinical applications and their outstanding concerns

21 January 2018

1 reference

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets

21 January 2018

1 reference

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

21 January 2018

1 reference

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways

21 January 2018

1 reference

The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation

21 January 2018

1 reference

The anti-adipogenic effect of macrophage-conditioned medium requires the IKKβ/NF-κB pathway.

21 January 2018

1 reference

Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DGD.12124

1 reference

19 October 2017

1 reference